Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bogus claims found despite evasive tactics

This article was originally published in The Tan Sheet

Executive Summary

Michigan businessman Tony Pham faces up to 25 years in prison and $500,000 in fines after pleading guilty to fraudulently marketing dietary supplements online with illegal claims that the products could prevent, treat or cure diseases, including diabetes. The U.S. Attorney's Office for the Western District of Missouri said July 2 that Pham in 2005 and 2006 sold $11.95 million in supplements from Web sites operated by Techmedica Health, Inc., of Grand Rapids. Pham, who will forfeit his sales from those years, claimed six products were "proven reliable through clinical testing" for treating and preventing various diseases. He fabricated testimonials and professional endorsements, and impeded FDA's investigation by using "mirror image technology" to display a different version of his Web sites when accessed from FDA network computers, according to a release. Under FDA regulations, Techmedia's products are unapproved and misbranded drugs because their labels do not bear adequate directions for use. A sentencing hearing will be scheduled later





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts